South Africa says most J&J doses could come from local firm Aspen

South Africa's health minister said on Wednesday that most of the Johnson & Johnson COVID-19 vaccine supply for South Africa and the rest of Africa could come from local pharmaceutical company Aspen.

Minister Zweli Mkhize added at a virtual briefing to parliament that South Africa was discussing possible joint research work on Russia's Sputnik V vaccine and that China's Sinopharm had applied to regulator SAHPRA for registration of its vaccine.